Spotlight on Siponimod and Its Potential in the Treatment of Secondary Progressive Multiple Sclerosis: The Evidence to Date

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s122249
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Spotlight on Tocilizumab and Its Potential in the Treatment of Systemic Sclerosis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Evidence to Date: Ranibizumab and Its Potential in the Treatment of Retinopathy of Prematurity

Eye and Brain
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Progressive Multiple Sclerosis: The Treatment Gap

Nature
Multidisciplinary
2012English

Profile of Buparlisib and Its Potential in the Treatment of Breast Cancer: Evidence to Date [Corrigendum]

Breast Cancer: Targets and Therapy
Oncology
2018English

Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
2018English

Spotlight on Afatinib and Its Potential in the Treatment of Squamous Cell Lung Cancer: The Evidence So Far

Therapeutics and Clinical Risk Management
2016English

New Possibilities for the Therapy of Secondary Progressive Multiple Sclerosis

Nevrologiya, Neiropsikhiatriya, Psikhosomatika
PsychiatryClinical PsychologyMental HealthNeurology
2019English

Motor Evoked Potentials and Disability in Secondary Progressive Multiple Sclerosis

Canadian Journal of Neurological Sciences
MedicineNeurology
1997English

The Efficacy and Safety of Daclizumab and Its Potential Role in the Treatment of Multiple Sclerosis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy